March 18, 2024 |
We’re diving into the state of pharmaceutical meetings and events in 2024 and–once and for all–put the idea of in-person meetings being superior to rest.

Whether we’re talking offices, medical congresses, or advisory board meetings, the term “hybrid” is often used to signal the ideal state. The place where everyone’s needs are being met. The best of both worlds. In the era of digital transformation, it is predicted that 2024 will be the year that finally cements hybrid meetings as the norm (1), with all-virtual meetings continuing to be a popular option. Yet, some people are holding onto the idea of in-person meetings being superior. In this article, we’re diving into the state of pharmaceutical meetings and events in 2024 and–once and for all–put this idea to rest.
I’ve written and talked about the blindspots of in-person meetings for over 16 years now, but it’s only been in the past few years that the benefits of virtual engagements have gained mainstream acceptance. There are multiple reasons why in-person-only meetings should be laid to rest, including, but not limited to, the facts that they are:
Specifically for advisory boards and other insight-gathering initiatives, the in-person-only approach comes with additional pain points such as:
Most important, though, is the fact that participants don’t want only in-person meetings. Based on our survey of hundreds of healthcare provider advisors in 2022–2023, over three-quarters stated that they prefer virtual/hybrid meetings, with the convenience and flexibility of digital meetings rated as the top benefits…
This content was provided by Impetus Digital
Company Details
Latest Content from Impetus Digital
Learn how our client used Impetus Digital’s virtual tools and services to develop and execute a national educational webinar on telehealth.
In the latest episode of Impetus Digital’s Fireside Chat, we dive into the concept of merging art and science with Ariel Garten, Founder & Chief Evangelism Officer at Muse. Ariel…
In this session, we discussed the processes involved in systems innovation and reviewed a few examples. We examined the transformational changes that can evolve over time when we go beyond…
Natalie Yeadon shares her expertise on how you can make the most out of your asynchronous virtual meetings and ask effective questions virtually.
Ryan Wiley, President of Shift Health, discusses healthcare’s journey towards digitalization and the ramifications COVID-19 has had in many of these areas. We also talk about Ryan’s shift from academia to consulting…
Tom Hsu, VP of Specialty Medicine at Bayer Canada, talks about how he got to where he is today and his experience working for Bayer in China, and how that compares to…
Ryan Zarychanski, Paul Komenda, and Marshall Pitz from MindSet, discuss a whole range of thought-provoking topics, including the barriers to and benefits of clinical data integration for the healthcare system, clinical trials, providers,…
Stephany Lapierre, Founder and CEO of Tealbook sits down with us in this Fireside Chat. Stephany is a highly coveted supply chain thought-leader, and one of the most influential minds in…
Jon Sockell, Co-founder and COO of Limbix, sits down with us in this Fireside Chat. See how Limbix is paving the way for prescription digital therapeutics and learn from their trials,…
In this session, we discussed systems change, wicked problems, and multisolving. We reviewed the transformational changes that can evolve and go beyond “cause and effect” thinking. In this dialogue, we…
